Journal of Clinical Endocrinology & Metabolism, Vol 48, 887-889, Copyright © 1979 by Endocrine Society

ARTICLES

Regulatory role of triiodothyronine in the degradation of low density lipoprotein by cultured human skin fibroblasts

A Chait, EL Bierman and JJ Albers

Degradation of [125I]-labeled low density lipoprotein (LDL) by cultured normal human skin fibroblasts was enhanced by exposure to concentrations of L-triiodothyronine (T3) spanning the physiological range. Analysis of LDL concentration curves suggests that T3 may increase LDL receptor number rather than alter the affinity of LDL for its receptor. No effect of T3 on LDL degradation was observed in receptor negative cells. Thus thyroid hormone appears to regulate receptor-mediated LDL degradation by increasing the binding of the lipoprotein to its cell-surface receptor.

This article has been cited by other articles:

				A. Roos, S. J. L. Bakker, T. P. Links, R. O. B. Gans, and B. H. R. Wolffenbuttel Thyroid Function Is Associated with Components of the Metabolic Syndrome in Euthyroid Subjects J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 491 - 496. [Abstract] [Full Text] [PDF]

				A. R. Cappola and P. W. Ladenson Hypothyroidism and Atherosclerosis J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2438 - 2444. [Full Text] [PDF]

				S. J. L. Bakker, J. C. ter Maaten, C. Popp-Snijders, J. P. J. Slaets, R. J. Heine, and R. O. B. Gans The Relationship between Thyrotropin and Low Density Lipoprotein Cholesterol Is Modified by Insulin Sensitivity in Healthy Euthyroid Subjects J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1206 - 1211. [Abstract] [Full Text]

				M. J. M. Diekman, N. Anghelescu, E. Endert, O. Bakker, and W. M. Wiersinga Changes in Plasma Low-Density Lipoprotein (LDL)- and High-Density Lipoprotein Cholesterol in Hypo- and Hyperthyroid Patients Are Related to Changes in Free Thyroxine, Not to Polymorphisms in LDL Receptor or Cholesterol Ester Transfer Protein Genes J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1857 - 1862. [Abstract] [Full Text]

				T. Diekman, P. N. M. Demacker, J. J. P. Kastelein, A. F. H. Stalenhoef, and W. M. Wiersinga Increased Oxidizability of Low-Density Lipoproteins in Hypothyroidism J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1752 - 1755. [Abstract] [Full Text]

				K. C. B. Tan, S. W. M. Shiu, and A. W. C. Kung Plasma Cholesteryl Ester Transfer Protein Activity in Hyper- and Hypothyroidism J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 140 - 143. [Abstract] [Full Text]

				V. Sundaram, A. N. Hanna, L. Koneru, H. A. I. Newman, and J. M. Falko Both Hypothyroidism and Hyperthyroidism Enhance Low Density Lipoprotein Oxidation J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3421 - 3424. [Abstract] [Full Text] [PDF]

				A. H. Taylor, Z. F. Stephan, R. E. Steele, and N. C. W. Wong Beneficial Effects of a Novel Thyromimetic on Lipoprotein Metabolism Mol. Pharmacol., September 1, 1997; 52(3): 542 - 547. [Abstract] [Full Text]

				M. Brown, P. Kovanen, and J. Goldstein Regulation of plasma cholesterol by lipoprotein receptors Science, May 8, 1981; 212(4495): 628 - 635. [Abstract] [PDF]